Condensed Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Cash flows from operating activities:
Net loss	$ (28,788,694)	$ (22,851,766)
Adjustments to reconcile net loss to net cash used for operations:
Depreciation	161,981	240,206
Stock-based compensation	3,498,784	1,689,331
Issuance of common stock, licensing agreement		5,000,000
Amortization of debt issuance costs and discount	284,184	173,361
Payment-in-Kind interest	311,764	196,348
Non-cash operating lease, net	(2,791)	(7,681)
Loss on sale of fixed assets		263
Changes in operating assets and liabilities:
Payroll tax receivable	37,838	(166,309)
Prepaid assets and deposits	(5,855,575)	(120,311)
Accounts payable	1,553,176	1,553,381
Accrued expenses	2,270,422	105,239
Net cash used for operating activities	(26,528,911)	(14,187,938)
Cash flows from investing activities:
Purchases of property and equipment	(46,724)	(71,959)
Proceeds from sale of property and equipment		500
Net cash used for investing activities	(46,724)	(71,459)
Cash flows from financing activities:
Proceeds from exercise of common stock warrants		11,257
Proceeds from exercise of employee stock options	24,233	41,959
Proceeds from employee stock purchases	80,541	25,817
Proceeds from follow-on offering, net of underwriting discounts and offering costs		78,530,585
Proceeds from note payable, net of debt issuance costs and discount of $652,061		14,347,939
Payments for debt issuance costs	(8,463)
Gross proceeds from an ATM offering		38,962
Payments for secondary registration statement costs	(318,897)	(3,868)
Payments for finance leases	(4,384)	(4,353)
Net cash (used for) provided by financing activities	(226,970)	92,988,298
Net change in cash and cash equivalents	(26,802,605)	78,728,901
Cash and cash equivalents:
Beginning of period	84,286,381	11,637,911
End of period	57,483,776	90,366,812
Supplemental disclosure of cash flow information:
Interest paid	832,161	454,573
Supplemental disclosures of non-cash investing and financing activities:
Property and equipment included in accounts payable	104,818
Offering and registration statement costs included in accounts payable	11,230
Deferred financing costs and offering and registration statement costs included in accrued expenses	205,000
Issuance of common stock warrants and final fee recognized as discount to note payable		$ 964,839